Gov. Gavin Newsom floats the idea of a 'price gouging penalty' for gasoline
Miranda Devine can't help but notice which WaPo articles Dems are putting on...
Gavin Newsom's Old Interview Reveals His Anger Issues
NYC officials to distribute fliers urging illegals to STAY AWAY from their sanctuary...
Try not to get emotional as Dems point to 'the only thing the...
Look on Jonathan Turley's face as AOC tries a 'gotcha' during Biden impeachment...
Was This the Worst Debate Moderator Yet?
Breanna Morello who was forced OUT at Fox News for refusing vaxx OWNS...
WH spox & Hunter Biden's lawyer spotted NOT having the same spin
Gosh, these sound FAMILIAR: Chaya Raichik shares list of words getting conservatives demon...
Riley Gaines DROPS AOC like the sack of STUPID she is for trying...
The Second Republican Debate Was a Dumpster Fire
John Fetterman's big PRANK he pulled on Repubs behind Biden impeachment inquiry fails...
Dems, media conveniently leaving out part of Jonathan Turley's quote about Biden impeachme...
A bunch of kids occupied Speaker McCarthy's office today ... but don't call...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.


More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.


Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member


Trending on Twitchy Videos